Endocrine and Gastroenterology
IMS basic and clinical science researchers explore the mechanisms governing gut, liver and hormone regulation to deepen our understanding and better treat conditions like diabetes, hepatitis B and C, inflammatory bowel disease, obesity, thyroid diseases, and more.
Our scientists also study how the human body responds when essential chemical messengers - crucial for controlling and regulating critical biological processes - become disrupted and malfunction.
Search our faculty directory for experts in this field.
Student Research
Highlights
In addition to diabetes and weight loss, GLP-1 drugs are now targeting cardiovascular, kidney and metabolic liver disease, sleep apnea and more.
Episode #100 - 100 Years Later: Insulin and Beyond
100 years since the discovery of insulin, a life saving treatment for diabetes that happened here at the University of Toronto. This discovery earned the scientists behind it the 1923 Nobel Prize in Medicine, and was a pivotal moment in Canadian medical science research.
Sinai Health and University of Toronto researchers have shown a blood test can predict Crohn’s disease years before symptoms appear, opening the doors to early diagnosis and potentially prevention.
Inflammatory bowel disease is on the rise worldwide. In Canada, the number of cases is predicted to increase by approximately 1.3-fold by 2035.